PLK4 and hepatocellular carcinoma: Lack of FAM46C/TENT5C function, now revealed as a frequent and prognostic feature in human colorectal cancer as well as in multiple myeloma and hepatocellular carcinoma, can promote tumor progression by allowing unrestrained Plk4 activity.